Dr. Fletcher founded and leads Bios Research, which provides healthcare equity research focused on biotech and med-tech for institutional firms and large family offices. He holds a PhD in Biochemistry from Colorado State University.
Dr. Daniel Billadeau is Professor and Chair of Immunology and Deputy Director for Basic Science at the Mayo Clinic Comprehensive Cancer Center. His research has focused on identifying molecular targets.
Dr. John Marshall trained at Duke University, the University of Louisville, and Georgetown University. He specializes in drug development and clinical trials for GI cancer, with a primary focus on precision medicine.
Dr. Lee Ellis holds the Ruben Distinguished Chair in Gastroenterology Cancer Research and is a professor at the University of Texas MD Anderson Cancer Center. He served on the ASCO Board of Directors and co-chaired an NCI committee until May 2022.
